{
    "2019-09-10": [
        [
            {
                "time": "",
                "original_text": "华鑫证券：医药生物板块业绩增长稳健 配置价值显著",
                "features": {
                    "keywords": [
                        "医药生物",
                        "业绩增长",
                        "配置价值"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业半年报业绩综述:内部仍在分化,龙头业绩亮眼",
                "features": {
                    "keywords": [
                        "医药行业",
                        "半年报",
                        "业绩分化",
                        "龙头业绩"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}